BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3093370)

  • 1. Production and characterization of pepsin fragments of human IgA1 to determine domain-specificity of monoclonal anti-IgA antibodies.
    Biewenga J; Faber A; Pronk JC; Haaijman JJ
    Immunology; 1986 Sep; 59(1):153-8. PubMed ID: 3093370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA1 half molecules in human multiple myeloma and the in vitro production of similar fragments from intact IgA1 molecules.
    Biewenga J; Van Loghem E
    Clin Exp Immunol; 1983 Feb; 51(2):395-400. PubMed ID: 6839548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies against different domains of human IgA: specificities determined by immunoblotting and haemagglutination-inhibition.
    Biewenga J; Faber A; de Lange G; van Leeuwen F; van Eede P; Jefferis R; Haaijman JJ; Vlug A
    Mol Immunol; 1986 Jul; 23(7):761-7. PubMed ID: 2432412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of limited reduction on disulfide bonds in human IgA1 and IgA1 fragments.
    Biewenga J; van Run PE
    Mol Immunol; 1992 Mar; 29(3):327-34. PubMed ID: 1557043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human myeloma IgA half-molecules.
    Spiegelberg HL; Fishkin BG
    J Clin Invest; 1976 Nov; 58(5):1259-65. PubMed ID: 993344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of immunoglobulin-cross-reactive molecules by neoplastic human T cells. I. Surface detection and isolation of molecules reactive with chicken anti-F(ab')2, anti-alpha and anti-mu antibodies.
    Haegert DG; Timm M
    Immunology; 1983 Nov; 50(3):447-59. PubMed ID: 6195097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human myeloma IgA with a hybrid heavy chain resulting from putative somatic gene conversion.
    Silvain C; Aucouturier P; Leduc I; Mihaesco E; Preud'homme JL; Cogné M
    Eur J Immunol; 1993 Feb; 23(2):364-8. PubMed ID: 8436172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of protein A-binding IgA1 with IgA1 protease from Streptococcus sanguis.
    Biewenga J; Daus F
    Immunol Commun; 1983 Oct; 12(5):491-500. PubMed ID: 6358000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid.
    Ryan MH; Petrone D; Nemeth JF; Barnathan E; Björck L; Jordan RE
    Mol Immunol; 2008 Apr; 45(7):1837-46. PubMed ID: 18157932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG antibodies to secretory component in normal human serum.
    Splawski JB; Woodard CS; Denney RM; Goldblum RM
    J Immunol; 1984 Oct; 133(4):2111-5. PubMed ID: 6332148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal human sera contain antibodies directed at Fab of IgA.
    Jackson S; Montgomery RI; Mestecky J; Czerkinsky C
    J Immunol; 1987 Apr; 138(7):2244-8. PubMed ID: 3494062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential susceptibility of human IgA immunoglobulins to streptococcal IgA protease.
    Plaut AG; Wistar R; Capra JD
    J Clin Invest; 1974 Dec; 54(6):1295-300. PubMed ID: 4436434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural human IgG anti-F(ab')2 antibody recognizes a conformational IgG1 hinge epitope.
    Terness P; Kohl I; Hübener G; Battistutta R; Moroder L; Welschof M; Dufter C; Finger M; Hain C; Jung M
    J Immunol; 1995 Jun; 154(12):6446-52. PubMed ID: 7539020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible aggregation of the Fc fragment derived from polymeric but not monomeric serum IgA1--implications in IgA-mediated disease.
    Almogren A; Kerr MA
    Mol Immunol; 2008 Jan; 45(1):87-94. PubMed ID: 17606293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of antigenic determinants on human IgA1.
    Biewenga J; Oliemans J; Daus F; de Lange G; van Eede P; van Leeuwen F; van Loghem E
    Vox Sang; 1983; 45(6):426-31. PubMed ID: 6197812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an antiserum specific for the Fabalpha fragment. Its use for detection of alpha-heavy chain disease protein by immunoselection.
    Doe WF; Spiegelberg HL
    J Immunol; 1979 Jan; 122(1):19-23. PubMed ID: 762416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two new peptic fragments of human IgA: F(abc)'2Alpha and [F(abc)'2]2alpha (author's transl)].
    Rivat C; Bourguignon J; Fontaine M; Ropartz C
    Ann Immunol (Paris); 1977; 128(1-2):183-4. PubMed ID: 322578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies against isotypic and isoallotypic determinants of human IgA1 and IgA2: fine specificities and binding properties.
    Delacroix DL; Van Snick J; Vaerman JP; Conley ME; Mascart-Lemone F; Bernier GM
    Mol Immunol; 1986 Apr; 23(4):367-75. PubMed ID: 2425248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Fc alpha receptor expression is linked to increased immunoglobulin A levels and disease progression in HIV-1-infected patients.
    Grossetête B; Viard JP; Lehuen A; Bach JF; Monteiro RC
    AIDS; 1995 Mar; 9(3):229-34. PubMed ID: 7755910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
    Boehm MK; Woof JM; Kerr MA; Perkins SJ
    J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.